Wheeler Bio Partners with MindImmune to Advance Alzheimer’s Drug
Wheeler Bio, a contract development and biomanufacturing organization based in the United States, has announced a significant partnership with MindImmune Therapeutics to support the development of its lead program, MITI-101,…